Latest Industry Insights
Industry Insight
Women in Science – A Conversation With Dr. Joanne Mason
In this interview, Dr. Mason tells us about her career path and experiences along the way, as well as sharing advice for women considering a career in science.
Industry Insight
Women in Science: From Lab to Leadership
In this opinion piece, Amy Butler shares her career path from lab to leadership, including how she was able to rise up in the ranks despite being an introvert.
Industry Insight
Time Is of the Essence: Saliva-Based Test Could Detect Cancer Early
Technology Networks spoke to Nick Ainslie, co-founder of Ausel, to find out more about a saliva-based diagnostic designed to indicate the presence of cancer cells at the earliest stage of development without the need for invasive methods.
Industry Insight
The Ethical Implications of AI in Scientific Publishing
As the use of generative AI tools expands, and their potential in scientific research is better understood, there are ethical considerations to be made. Dr. Dror Kolodkin-Gal explores some of the issues and potential solutions.
Industry Insight
Increasing Widespread Accessibility of Molecular Testing for Oncology Research
Bio-Rad's Jeremiah McDole explores the benefits of bringing molecular testing in-house and how ddPCR technology can be applied in oncology workflows.
Industry Insight
Shaping the Future of Genomic Medicine
In this interview, James Brayer delves into some of the current obstacles hindering the widespread adoption of genomic medicine and highlights how nanopore-based sequencing can help to address them.
Industry Insight
Addressing One of the Most Common Dilemmas Faced by Oncologists
Technology Networks spoke to Dr. Ofer Sharon, CEO of OncoHost, to learn about the challenges in non-small cell lung cancer treatment and how proteomics-based analysis could enable personalized cancer treatments.
Industry Insight
Novel Prostate Cancer Screening Methods To Reduce Unnecessary Biopsies
This article looks at the technologies currently being developed that can help to identify patients with a higher risk of prostate cancer, ultimately reducing the number of unnecessary biopsies.
Industry Insight
Why the Time Is Now for Allogeneic Cell Therapies
Andrew Schulman explores why we need allogeneic therapies, the importance of collaboration to keep the momentum, and challenges and predictions for the future.
Industry Insight
What Does Sustainability Accreditation Really Mean for Scientific Companies?
With growing sustainability demands, companies are looking for ways to demonstrate their green credentials. We spoke to Dr. Michael Frank to find out what ACT accreditation means for a company and why he thinks schemes like this are so important.
Advertisement